FIELD: biotechnology; medicine.
SUBSTANCE: invention relates to biotechnology, specifically to calcitonin mimetics, and can be used in medicine. A calcitonin mimetic is a polypeptide with SEQ ID NO: 44, acetylated on the N-terminus and amidated at the C-terminal.
EFFECT: invention can be used as a part of pharmaceutical compositions for effective treatment of diabetes mellitus, excess body weight, non-alcoholic fatty dystrophy, osteoporosis or osteoarthritis.
20 cl, 17 dwg, 5 tbl, 7 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PEPTIDE ANALOGS FOR TREATMENT OF DISEASES AND DISORDERS | 2012 |
|
RU2616511C2 |
| TREATING DIABETES AND METABOLIC SYNDROME | 2010 |
|
RU2537181C2 |
| METHOD FOR TREATING DIABETES TYPE II WITH AMYLENE ANTAGONISTS | 1996 |
|
RU2166958C2 |
| METHODS OF REGULATION OF GASTROENTERIC TRACT MOTOR SYSTEM | 1994 |
|
RU2177331C2 |
| PHARMACEUTICAL COMPOSITIONS CONTAINING HGH FOR ORAL ADMINISTRATION | 2007 |
|
RU2493868C2 |
| CRYSTALLINE FORMS OF DISODIUM SALT OF N-(5-CHLOROSALICILOUL-)-8-AMINOCAPRYLIC ACID | 2006 |
|
RU2507196C2 |
| PEPTIDE HAVING AMYLIN PROPERTIES (VERSIONS) AND USE THEREOF (VERSIONS) | 2005 |
|
RU2385878C2 |
| METHOD FOR TREATMENT OR PROPHYLAXIS OF OBESITY | 2002 |
|
RU2314121C9 |
| APPLICATION OF CALCITONIN FOR TREATING RHEUMATOID ARTHRITIS | 2006 |
|
RU2453330C2 |
| ACTIVE SUBSTANCE DELIVERY | 2008 |
|
RU2467741C2 |
